Claremont Biosolutions has developed a family of proprietary products for the ultra-fast mechanical lysis of cells, the extraction and purification of genomic DNA, and the cost-effective, real-time detection of amplified DNA sequences. Claremont BioSolutions has focused on developing products that combine speed with ease-of-use.

Claremont Biosolutions is also the inventor of The SimplePrep®:

SimplePrep® X8 is an all-in-one automated cell lysis and nucleic acid extraction instrument designed to rapidly isolate DNA or RNA from hard-to-lyse bacterial samples within complex sample matrices in only 6 minutes. Samples are rapidly lysed and subsequently purified in a true hands-free workflow without the need for tedious centrifuge steps or time-consuming incubation periods. The SimplePrep® X8 utilizes self-contained, disposable cartridges to rapidly extract nucleic acids from 1 to 8 samples all-at-once, providing high yields of PCR-ready nucleic acids even when high concentrations of PCR inhibitors are present.

The agreement covers sales to the the following countries:
Norway, Denmark, Iceland, Finland, Sweden and Germany

High Performance Secondary Analysis of Genomic Data: Parabricks provides 30-50 times faster secondary analysis of FASTQ files coming out of sequencers to VCF files that have the variants for tertiary analysis.

Parabricks accelerates existing GATK best practices to generate equivalent results as the baseline CPU-only solution.

• Secondary Analysis In An Hour Instead Of Days
• Accelerated Genomic Analysis

• Product sheet

CENTOGENE is a rare disease company focused on transforming clinical, genetic, and biochemical data into medical solutions for Patients. With headquarters in Rostock, Germany, and further operations in Berlin, Germany as well as Cambridge, Massachusetts, USA, CENTOGENE is dedicated to transforming the science of genetic information into solutions and hope for patients with rare diseases and their families.

CENTOGENE provides the full spectrum of modern methods and technology for human genetics analysis; it is active in research and is constantly developing new and innovative products for human genetics.

NVIDIA is an American technology company incorporated in Delaware and based in Santa Clara, California. It designs graphics processing units (GPUs) for the gaming and professional markets, as well as system on a chip units (SoCs) for the mobile computing and automotive market.

Since 2014, Nvidia has diversified its business focusing on four markets – gaming, professional visualisation, data centers and auto. Nvidia is also now focused on artificial intelligence.

In addition to GPU manufacturing, Nvidia provides parallel processing capabilities to researchers and scientists that allow them to efficiently run high-performance applications. They are deployed in supercomputing sites around the world.

Fueled by the insatiable demand for better 3D graphics, and the massive scale of the gaming market, NVIDIA has evolved the GPU into a computer brain at the exciting intersection of virtual reality, high performance computing, and artificial intelligence.

Description

DataDirect Networks, Inc. (DDN) is the world leader in large scale data storage for Life Sciences and Genomics.

Approximately half of all large genomics centers globally use DDN as their main data storage provider in sequencing applications, genomic pipelines and data collaboration solutions.

DDN is the world’s leading big data storage supplier to data-intensive, global organizations. For more than 18 years, DDN has developed, deployed and optimized systems, software and storage solutions that enable enterprises, service providers, research and government agencies to generate more value and to accelerate time to insight from their data, on premise and in the cloud. Organizations leverage the power of DDN storage technology and the deep technical expertise of its team to capture, store, analyze, collaborate and distribute information and content at the largest scale in the most efficient, reliable and cost-effective manner. DDN customers include many of the world’s leading healthcare and life science organizations, manufacturing and energy companies, government and research facilities, and web and cloud service providers.

Loop Genomics has developed a synthetic long-read sequencing technology that leverages existing Illumina® short read sequencers coupled with LoopSeq® barcoding technology to enable single-molecule, long-read sequencing on any Illumina® infrastructure.

• Learn more about the technology
• Download the manuals and quickguides